Search results
Found 98 matches for
As part of its commitment to developing better medicines for Duchenne Muscular Dystrophy (DMD), WAVE has extended its ongoing research collaboration with the University of Oxford to advance stereopure nucleic acid therapies for DMD across exons.
Annual Dementia Awareness Day
Outreach
Saturday, 22 March 2014
Sally Magnusson launches UK’s biggest dementia research conference in Oxford.